The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
p53-mediated cell death: relationship to cell cycle control.
Open accessAbstract
M1 clone S6 myeloid leukemic cells do not express detectable p53 protein. When stably transfected with a temperature-sensitive mutant of p53, these cells undergo rapid cell death upon induction of wild-type (wt) p53 activity at the permissive temperature. This process has features of apoptosis. In a number of other cell systems, wt p53 activation has been shown to induce a growth arrest. Yet, wt 53 fails to induce a measurable growth arrest in M1 cells, and cell cycle progression proceeds while viability is being lost. There exists, however, a relationship between the cell cycle and p53-mediated death, and cells in G1 appear to be preferentially susceptible to the death-inducing activity of wt p53. In addition, p53-mediated M1 cell death can be inhibited by interleukin-6. The effect of the cytokine is specific to p53-mediated death, since apoptosis elicited by serum deprivation is refractory to interleukin-6. Our data imply that p53-mediated cell death is not dependent on the induction of a growth arrest but rather may result from mutually incompatible growth-regulatory signals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
The p53 tumour suppressor gene
Levine, A. J., Momand, J., & Finlay, C. A. (1991) · Nature · doi:10.1038/351453a0 · Cited by 3,788
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
Hockenbery, D., Nuñez, G., Milliman, C., Schreiber, R. D., & Korsmeyer, S. J. (1990) · Nature · doi:10.1038/348334a0 · Cited by 3,720
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
Vaux, D. L., Cory, S., & Adams, J. M. (1988) · Nature · doi:10.1038/335440a0 · Cited by 3,219
Induction of apoptosis in fibroblasts by c-myc protein
Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., & Hancock, D. C. (1992) · Cell · doi:10.1016/0092-8674(92)90123-t · Cited by 2,935
The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S.-I., Sameshima, M., Hase, A., Seto, Y., & Nagata, S. (1991) · Cell · doi:10.1016/0092-8674(91)90614-5 · Cited by 2,737
Social controls on cell survival and cell death
Raff, M. C. (1992) · Nature · doi:10.1038/356397a0 · Cited by 2,604
Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6
Yonish-Rouach, E., Resnftzky, D., Lotem, J., Sachs, L., Kimchi, A., & Oren, M. (1991) · Nature · doi:10.1038/352345a0 · Cited by 2,079
Self-citationWild-type p53 is a cell cycle checkpoint determinant following irradiation.
Kuerbitz, S. J., Plunkett, B. S., Walsh, W. V., & Kastan, M. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7491 · Cited by 1,837
Suppression of Human Colorectal Carcinoma Cell Growth by Wild-Type p53
Baker, S. J., Markowitz, S., Fearon, E. R., Willson, J. K. V., & Vogelstein, B. (1990) · Science · doi:10.1126/science.2144057 · Cited by 1,754
Apoptosis: Mechanisms and Roles in Pathology
ARENDS, M. J., & WYLLIE, A. H. (1991) · International Review of Experimental Pathology · doi:10.1016/b978-0-12-364932-4.50010-1 · Cited by 1,334
BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death.
Hockenbery, D. M., Zutter, M., Hickey, W., Nahm, M., & Korsmeyer, S. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.16.6961 · Cited by 1,252
bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes
Sentman, C. L., Shutter, J. R., Hockenbery, D., Kanagawa, O., & Korsmeyer, S. J. (1991) · Cell · doi:10.1016/0092-8674(91)90361-2 · Cited by 1,194
Henderson, S., Rowe, M., Gregory, C., Croom-Carter, D., Wang, F., Longnecker, R., Kieff, E., & Rickinson, A. (1991) · Cell · doi:10.1016/0092-8674(91)90007-l · Cited by 1,168
Apoptosis And Programmed Cell Death In Immunity
Cohen, J. (1992) · Annual Review of Immunology · doi:10.1146/annurev.immunol.10.1.267 · Cited by 1,111
bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship
Strasser, A., Harris, A. W., & Cory, S. (1991) · Cell · doi:10.1016/0092-8674(91)90362-3 · Cited by 1,054
Oncogenic forms of p53 inhibit p53-regulated gene expression
Kern, S., Pietenpol, J., Thiagalingam, S., Seymour, A., Kinzler, K., & Vogelstein, B. (1992) · Science · doi:10.1126/science.1589764 · Cited by 940
Askew, D. S., Ashmun, R. A., Simmons, B. C., & Cleveland, J. L. (1991) · PubMed · Cited by 867
Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line.
Shaw, P., Bovey, R., Tardy, S., Sahli, R., Sordat, B., & Costa, J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4495 · Cited by 848
Presence of a Potent Transcription Activating Sequence in the p53 Protein
Fields, S., & Jang, S. K. (1990) · Science · doi:10.1126/science.2144363 · Cited by 790
p53 functions as a cell cycle control protein in osteosarcomas.
Diller, L., Kassel, J., Nelson, C. E., Gryka, M. A., Litwak, G., Gebhardt, M., Bressac, B., Ozturk, M., Baker, S. J., & Vogelstein, B. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.11.5772 · Cited by 772
Michalovitz, D., Halevy, O., & Oren, M. (1990) · Cell · doi:10.1016/0092-8674(90)90113-s · Cited by 769
Self-citationA transcriptionally active DNA-binding site for human p53 protein complexes.
Funk, W. D., Pak, D. T., Karas, R. H., Wright, W. E., & Shay, J. W. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.6.2866 · Cited by 732
Transcriptional Activation by Wild-Type but Not Transforming Mutants of the p53 Anti-Oncogene
Raycroft, L., Wu, H., & Lozano, G. (1990) · Science · doi:10.1126/science.2144364 · Cited by 619
Wild-type p53 activates transcription in vitro
Farmer, G., Bargonetti, J., Zhu, H., Friedman, P., Prywes, R., & Prives, C. (1992) · Nature · doi:10.1038/358083a0 · Cited by 579
TP53 tumor suppressor gene: A model for investigating human mutagenesis
Fromentel, C. C. D., & Soussi, T. (1992) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.2870040102 · Cited by 574
Apoptotic cell death and tissue remodelling during mouse mammary gland involution
Strange, R., Li, F., Saurer, S., Burkhardt, A., & Friis, R. R. (1992) · Development · doi:10.1242/dev.115.1.49 · Cited by 534
Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein.
Martinez, J., Georgoff, I., Martinez, J., & Levine, A. J. (1991) · Genes & Development · doi:10.1101/gad.5.2.151 · Cited by 527
Genetic Mechanisms of Tumor Suppression by the Human p53 Gene
Chen, P.-L., Chen, Y., Bookstein, R., & Lee, W.-H. (1990) · Science · doi:10.1126/science.2274789 · Cited by 518
Apoptosis-the molecular basis of cell death
Bowen, I. D. (1992) · Endeavour · doi:10.1016/0160-9327(92)90055-t · Cited by 517
Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells.
Oren, M., Maltzman, W., & Levine, A. J. (1981) · Molecular and Cellular Biology · doi:10.1128/mcb.1.2.101 · Cited by 489
Self-citationMercer, W. E., Shields, M. T., Amin, M., Sauve, G. J., Appella, E., Romano, J. W., & Ullrich, S. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.16.6166 · Cited by 477
Induction of the TRPM-2 gene in cells undergoing programmed death.
Buttyan, R., Olsson, C. A., Pintar, J., Chang, C., Bandyk, M., Ng, P. Y., & Sawczuk, I. S. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.8.3473 · Cited by 452
Cell Death Mechanisms and the Immune System
Golstein, P., Ojcius, D. M., & Young, J. D. (1991) · Immunological Reviews · doi:10.1111/j.1600-065x.1991.tb00822.x · Cited by 447
Apoptosis: The Molecular Basis of Cell Death
Tomei, L., & Cope, F. O. (1991) · Medical Entomology and Zoology · Cited by 438
Wild-type p53 can down-modulate the activity of various promoters.
Ginsberg, D., Mechta, F., Yaniv, M., & Oren, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.9979 · Cited by 435
Self-citationSanthanam, U., Ray, A., & Sehgal, P. B. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.17.7605 · Cited by 375
Zambetti, G. P., Bargonetti, J., Walker, K., Prives, C., & Levine, A. J. (1992) · Genes & Development · doi:10.1101/gad.6.7.1143 · Cited by 311
Identification of mRNAs Associated with Programmed Cell Death in Immature Thymocytes
Owens, G. P., Hahn, W. E., & Cohen, J. J. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.8.4177-4188.1991 · Cited by 278
Unger, T., Nau, M. M., Segal, S., & Minna, J. D. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05183.x · Cited by 261
Colombel, M. C., Olsson, C. A., Ng, P., & Buttyan, R. (1992) · PubMed · Cited by 242
Identification of mRNAs associated with programmed cell death in immature thymocytes.
Owens, G. P., Hahn, W. E., & Cohen, J. J. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.8.4177 · Cited by 241
Death by suicide: one way to go in mammalian cellular development?
Ucker, D. S. (1991) · PubMed · Cited by 209
p53: the ultimate tumor suppressor gene?
Oren, M. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.13.1397838 · Cited by 206
Self-citationResnitzky, D., Yarden, A., Zipori, D., & Kimchi, A. (1986) · Cell · doi:10.1016/0092-8674(86)90857-3 · Cited by 195
Self-citationGrowth suppression of human breast cancer cells by the introduction of a wild-type p53 gene.
Casey, G., LO-HSUEH, M., Lopez, M. E., Vogelstein, B., & Stanbridge, E. J. (1991) · PubMed · Cited by 189
Levels of p53 protein increase with maturation in human hematopoietic cells.
Kastan, M. B., Radin, A. I., Kuerbitz, S. J., Onyekwere, O. C., Wolkow, C., Civin, C. I., Stone, K. D., Woo, T. Y., Ravindranath, Y., & Craig, R. W. (1991) · PubMed · Cited by 188
The S-phase cytotoxicity of camptothecin
Del Bino, G., Lassota, P., & Darzynkiewicz, Z. (1991) · Experimental Cell Research · doi:10.1016/0014-4827(91)90534-2 · Cited by 187
Cannon, J. V., & Lane, D. P. (1991) · Nature · doi:10.1038/349802a0 · Cited by 173
Involvement of wild-type p53 in pre-B-cell differentiation in vitro.
Shaulsky, G., Goldfinger, N., Peled, A., & Rotter, V (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.20.8982 · Cited by 160
The MCK enhancer contains a p53 responsive element.
Weintraub, H., Hauschka, S., & Tapscott, S. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4570 · Cited by 159
Ginsberg, D., Michael, D., Ginsberg, D., & Oren, M. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.1.582 · Cited by 142
Self-citationAlterations in tumor development in vivo mediated by expression of wild type or mutant p53 proteins.
Shaulsky, G., Goldfinger, N., & Rotter, V. (1991) · PubMed · Cited by 132
Umansky, S. R. (1982) · Journal of Theoretical Biology · doi:10.1016/0022-5193(82)90360-5 · Cited by 124
Resnitzky, D., Tiefenbrun, N., Berissi, H., & Kimchi, A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.1.402 · Cited by 118
Self-citationHuman p53 and CDC2Hs Genes Combine To Inhibit the Proliferation of Saccharomyces cerevisiae
Nigro, J. M., Sikorski, R. S., Reed, S. I., & Vogelstein, B. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.3.1357 · Cited by 117
Analysis of p53 Mutants for Transcriptional Activity
Raycroft, L., Schmidt, J. R., Yoas, K., Hao, M., & Lozano, G. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.12.6067 · Cited by 113
Selvakumaran, M., Liebermann, D. A., & Hoffman‐Liebermann, B. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.6.2493 · Cited by 107
Merchant, S., Hill, K. L., & Howe, G. A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07658.x · Cited by 94
Jansen, J. H., Kluin‐Nelemans, H. C., Damme, J. V., Wientjens, G. J. H. M., Willemze, R., & Fibbe, W. E. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.175.4.1151 · Cited by 75
Protein-binding elements in the promoter region of the mouse p53 gene.
Ginsberg, D., Oren, M., Yaniv, M., & Piette, J. (1990) · PubMed · Cited by 73
Self-citationHoffman‐Liebermann, B., & Liebermann, D. A. (1991) · PubMed · Cited by 62
Zambetti, G. P., Olson, D., Labow, M., & Levine, A. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.3952 · Cited by 61
Maltzman, W., Oren, M., & Levine, A. J. (1981) · Virology · doi:10.1016/0042-6822(81)90620-6 · Cited by 40
Self-citation
Cited by
Hartwell, L. H., & Kastan, M. B. (1994) · Science · doi:10.1126/science.7997877 · Cited by 2,535
Ko, L. J., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,344
Meijer, L., Borgne, A., Mulner, O., Chong, J. P. J., Blow, J. J., Inagaki, N., Inagaki, M., Delcros, J., & Moulinoux, J. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.t01-2-00527.x · Cited by 1,352
Di Leonardo, A., Linke, S. P., Clarkin, K., & Wahl, G. M. (1994) · Genes & Development · doi:10.1101/gad.8.21.2540 · Cited by 1,215
Role of cell cycle in mediating sensitivity to radiotherapy
Pawlik, T. M., & Keyomarsi, K. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.03.005 · Cited by 1,102
Metadata
- Authors
- Yonish-Rouach, E., Grunwald, D., Wilder, S., Kimchi, A., May, E., Lawrence, J. J., May, P., & Oren, M.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1993-03
- Volume
- 13
- Issue
- 3
- Pages
- 1415-1423
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W1842375597
- Cited by
- 344
- References
- 66
- FWCI
- 18.58
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.